1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Prof
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office COP300
Email jamie-miller@ou.edu
Publications & Presentations
- 126. Miller J L, Hagemann T M. Use of pure opioid antagonists for management of opioid-induced pruritus. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2011; 68 : 1419-25
127. Johnson P N, Miller J L, Gormley A K. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children. Pharmacotherapy. 2011; 31 : 609-20
128. Johnson P N, Miller J L, Boucher E A, Lubsch L, Girotto J E, Pesaturo K A, Lee B. Pediatric Pharmacy Advocacy Group Position Statement: Medication dosing in overweight and obese children. 2010
129. Gish E C, Miller J L, Gildon B, Johnson P N. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification. The Annals of pharmacotherapy. 2010; 44 : 343-51
130. Miller J L, Johnson P N, Harrison D, Hagemann T M. Evaluation of inpatient admissions and potential antimicrobial and analgesic dosing errors in overweight children. The Annals of pharmacotherapy. 2010; 44 : 35-42
Grants
- 1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.
2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
Awards and Honors
- 11. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.
12. Rho Chi, Gamma Chapter. 2019 Chapter Alumni Award. Date: 2019.
13. Oklahoma Society of Health-System Pharmacists. Oklahoma Pharmacist of the Year. Date: 2019.
14. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.
15. Pediatric Pharmacy Association. Fellow of Pediatric Pharmacy Association. Date: 2018.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.